Synthesis Systems for Radioactively Labeled Pharmaceuticals

Summary

Universitätsklinikum Bonn is procuring three synthesis modules (Module A with two units and Module B with one unit) for automated production of radioactively labeled pharmaceuticals. Module A produces standard radiopharmaceuticals for nuclear medicine diagnostics and therapy in a closed system, ensuring consistent quality and staff radiation protection. Module B includes an integrated HPLC purification system for complex radiopharmaceuticals requiring chromatographic separation. The equipment will support the hospital's leading nuclear medicine program and enable development of new radioactive medicines.

Universitätsklinikum Bonn is procuring three synthesis modules (Module A with two units and Module B with one unit) for automated production of radioactively labeled pharmaceuticals. Module A produces standard radiopharmaceuticals for nuclear medicine diagnostics and therapy in a closed system, ensuring consistent quality and staff radiation protection. Module B includes an integrated HPLC purification system for complex radiopharmaceuticals requiring chromatographic separation. The equipment will support the hospital's leading nuclear medicine program and enable development of new radioactive medicines.